Education
About Us
Working with TipRanks
Follow Us
Harvard Bioscience (HBIO)
NASDAQ:HBIO
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.03Last Year’s EPS
0Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 12, 2025
|% Change Since: 3.13%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with several innovative product launches and improvements in cash flow and debt reduction. However, significant challenges such as a decline in revenue, reduced gross margins, a major goodwill impairment charge, and difficulties in the APAC market pose concerns. Despite these issues, there is optimism about new product adoption and potential recovery in the China market.Company Guidance
In the first quarter of 2025, Harvard Bioscience Inc. reported revenue of $21.8 million, which was slightly below the previous year's $24.5 million but aligned with the higher end of the guidance provided in March. The gross margin decreased to 56% from 60.3% in the same period last year. The company recognized a non-cash goodwill impairment charge of $48 million, leading to an operating loss of $49.7 million, compared to a $2.3 million loss in the first quarter of 2024. Excluding this charge, the adjusted operating income was $0.3 million, compared to $1.2 million in the prior year. Adjusted EBITDA was $0.8 million, down from $1.6 million in the previous year, primarily due to reduced revenue. Cash flow from operations improved to $3 million from $1.4 million in the prior year, attributed to better working capital management. The company also reduced its net debt by $1 million compared to the first quarter of 2024. Looking ahead, for the second quarter, the company expects revenue between $18 million and $20 million and plans to reduce operating expenses by an additional $1 million per quarter starting in the second quarter.New Product Launches and Expansions
Successful launch of new SoHo family of implanted telemetry devices and expansion to cardiac and neuromonitoring. The Viva Mars system was successfully delivered to Labcorp and discussions for additional sites are ongoing.
Growth in Bioproduction and CAR-T Therapy
Reached approximately $1 million in consumable revenue from the first large bioproduction customer. Exploring opportunities with a large biotech for bioproduction of a CAR-T therapy.
Improved Cash Flow from Operations
Cash flow from operations improved to $3 million during Q1 2025 compared to $1.4 million in Q1 last year, primarily driven by improvements in working capital management.
Debt Reduction
Net debt is down $1 million from Q1 2024 and $2.4 million from year-end '24, reflecting improved operating cash flow and quarterly principal payments.
Positive Indications for China Market
Good news regarding potential agreement with China, which is significant as China represents around 10% of revenue.
HBIO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HBIO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2025 | $0.32 | $0.35 | +9.37% |
Mar 12, 2025 | $0.76 | $0.68 | -10.53% |
Nov 07, 2024 | $2.82 | $2.39 | -15.25% |
Aug 08, 2024 | $2.79 | $3.12 | +11.83% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Harvard Bioscience (HBIO) report earnings?
Harvard Bioscience (HBIO) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Harvard Bioscience (HBIO) earnings time?
Harvard Bioscience (HBIO) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HBIO EPS forecast?
HBIO EPS forecast for the fiscal quarter 2025 (Q2) is -0.03.